Novocure
Jonathan Gephart, Ph.D., currently serves as a Senior Clinical Research Scientist at Novocure since January 2020. Previously, Jonathan held the position of Oncology Field Medical Director at Pfizer, where responsibilities included enhancing medical communication regarding the oncology portfolio in the southern United States. Jonathan's experience also includes managing clinical trials at Vanderbilt-Ingram Cancer Center and conducting research as a Graduate Research Associate at Vanderbilt University. With a Ph.D. in Cell and Developmental Biology from Vanderbilt University and additional credentials in Medical Affairs and Medicines Development, Jonathan possesses a strong foundation in clinical research and oncology.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.